Fluorine in PDB 8u0q: Co-Crystal Structure of Optimized Analog Tdi-13537 Provided New Insights Into the Potency Determinants of the Sulfonamide Inhibitor Series

Enzymatic activity of Co-Crystal Structure of Optimized Analog Tdi-13537 Provided New Insights Into the Potency Determinants of the Sulfonamide Inhibitor Series

All present enzymatic activity of Co-Crystal Structure of Optimized Analog Tdi-13537 Provided New Insights Into the Potency Determinants of the Sulfonamide Inhibitor Series:
1.8.1.4;

Protein crystallography data

The structure of Co-Crystal Structure of Optimized Analog Tdi-13537 Provided New Insights Into the Potency Determinants of the Sulfonamide Inhibitor Series, PDB code: 8u0q was solved by A.A.Dementiev, M.Michino, J.Vendome, J.Ginn, R.Bryk, A.Olland, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 45.53 / 1.69
Space group P 21 21 21
Cell size a, b, c (Å), α, β, γ (°) 83.335, 97.928, 123.806, 90, 90, 90
R / Rfree (%) 17.1 / 20.8

Fluorine Binding Sites:

The binding sites of Fluorine atom in the Co-Crystal Structure of Optimized Analog Tdi-13537 Provided New Insights Into the Potency Determinants of the Sulfonamide Inhibitor Series (pdb code 8u0q). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total 4 binding sites of Fluorine where determined in the Co-Crystal Structure of Optimized Analog Tdi-13537 Provided New Insights Into the Potency Determinants of the Sulfonamide Inhibitor Series, PDB code: 8u0q:
Jump to Fluorine binding site number: 1; 2; 3; 4;

Fluorine binding site 1 out of 4 in 8u0q

Go back to Fluorine Binding Sites List in 8u0q
Fluorine binding site 1 out of 4 in the Co-Crystal Structure of Optimized Analog Tdi-13537 Provided New Insights Into the Potency Determinants of the Sulfonamide Inhibitor Series


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Co-Crystal Structure of Optimized Analog Tdi-13537 Provided New Insights Into the Potency Determinants of the Sulfonamide Inhibitor Series within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F502

b:47.3
occ:1.00
F26 A:U4I502 0.0 47.3 1.0
C25 A:U4I502 1.4 39.9 1.0
F27 A:U4I502 2.2 45.0 1.0
C24 A:U4I502 2.3 30.6 1.0
C28 A:U4I502 2.9 27.0 1.0
CB A:GLU448 3.3 25.8 1.0
C23 A:U4I502 3.4 30.3 1.0
CD A:GLU448 3.5 33.5 1.0
OE2 A:GLU448 3.5 33.2 1.0
O A:HOH633 3.5 41.3 1.0
ND2 A:ASN382 3.7 29.6 1.0
OE1 A:GLU448 3.7 31.4 1.0
CA A:ASN382 4.0 24.2 1.0
CG A:GLU448 4.0 23.8 1.0
O A:ALA381 4.1 28.7 1.0
C19 A:U4I502 4.1 27.2 1.0
CG A:ASN382 4.2 31.9 1.0
N A:ALA383 4.2 26.3 1.0
CB A:ASN382 4.5 22.2 1.0
C21 A:U4I502 4.6 33.0 1.0
CA A:GLU448 4.6 24.7 1.0
C A:GLU448 4.7 27.7 1.0
CZ A:PHE377 4.7 29.6 1.0
C A:ASN382 4.7 23.2 1.0
O A:HOH616 4.8 36.6 1.0
C20 A:U4I502 4.9 30.1 1.0
CE2 A:PHE377 4.9 31.4 1.0
O A:GLU448 4.9 25.7 1.0
N A:ALA449 5.0 22.2 1.0
C A:ALA381 5.0 28.1 1.0
O A:THR445 5.0 24.4 1.0
N A:ASN382 5.0 28.8 1.0
OD1 A:ASN382 5.0 31.7 1.0

Fluorine binding site 2 out of 4 in 8u0q

Go back to Fluorine Binding Sites List in 8u0q
Fluorine binding site 2 out of 4 in the Co-Crystal Structure of Optimized Analog Tdi-13537 Provided New Insights Into the Potency Determinants of the Sulfonamide Inhibitor Series


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 2 of Co-Crystal Structure of Optimized Analog Tdi-13537 Provided New Insights Into the Potency Determinants of the Sulfonamide Inhibitor Series within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F502

b:45.0
occ:1.00
F27 A:U4I502 0.0 45.0 1.0
C25 A:U4I502 1.4 39.9 1.0
F26 A:U4I502 2.2 47.3 1.0
C24 A:U4I502 2.3 30.6 1.0
C28 A:U4I502 2.9 27.0 1.0
CB A:ASN463 3.2 27.4 1.0
C23 A:U4I502 3.4 30.3 1.0
ND2 A:ASN463 3.6 31.6 1.0
CG A:ASN463 3.7 32.0 1.0
CG A:GLU452 3.7 30.5 1.0
CZ A:PHE377 3.8 29.6 1.0
O A:ALA381 3.9 28.7 1.0
OE2 A:GLU452 4.0 42.3 1.0
C19 A:U4I502 4.2 27.2 1.0
CD A:GLU452 4.2 41.6 1.0
O3 A:GOL503 4.4 59.0 1.0
CE1 A:PHE377 4.4 30.1 1.0
OD1 A:ASN463 4.5 32.0 1.0
C21 A:U4I502 4.5 33.0 1.0
CB A:GLU448 4.6 25.8 1.0
CE2 A:PHE377 4.6 31.4 1.0
CA A:ASN463 4.7 27.1 1.0
OE2 A:GLU448 4.7 33.2 1.0
O A:HOH616 4.7 36.6 1.0
C20 A:U4I502 4.9 30.1 1.0
O A:GLU448 4.9 25.7 1.0

Fluorine binding site 3 out of 4 in 8u0q

Go back to Fluorine Binding Sites List in 8u0q
Fluorine binding site 3 out of 4 in the Co-Crystal Structure of Optimized Analog Tdi-13537 Provided New Insights Into the Potency Determinants of the Sulfonamide Inhibitor Series


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 3 of Co-Crystal Structure of Optimized Analog Tdi-13537 Provided New Insights Into the Potency Determinants of the Sulfonamide Inhibitor Series within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F523

b:39.6
occ:1.00
F26 A:U4I523 0.0 39.6 1.0
C25 A:U4I523 1.4 29.6 1.0
F27 A:U4I523 2.2 39.3 1.0
C24 A:U4I523 2.3 29.5 1.0
C28 A:U4I523 2.9 25.5 1.0
CB B:ASN463 3.2 26.2 1.0
C23 A:U4I523 3.4 25.3 1.0
CG B:ASN463 3.7 36.9 1.0
ND2 B:ASN463 3.7 32.6 1.0
CZ B:PHE377 3.7 29.0 1.0
CG B:GLU452 3.7 30.1 1.0
OE2 B:GLU452 3.8 37.9 1.0
O B:ALA381 3.9 25.7 1.0
C19 A:U4I523 4.1 27.6 1.0
CD B:GLU452 4.1 37.5 1.0
CE2 B:PHE377 4.3 28.2 1.0
CB B:GLU448 4.5 24.2 1.0
OE2 B:GLU448 4.6 29.6 1.0
C21 A:U4I523 4.6 25.7 1.0
OD1 B:ASN463 4.6 31.2 1.0
CE1 B:PHE377 4.6 25.2 1.0
CA B:ASN463 4.7 27.1 1.0
O B:HOH614 4.7 33.4 1.0
C20 A:U4I523 4.9 27.5 1.0
O B:GLU448 4.9 27.1 1.0
CD B:GLU448 5.0 33.6 1.0

Fluorine binding site 4 out of 4 in 8u0q

Go back to Fluorine Binding Sites List in 8u0q
Fluorine binding site 4 out of 4 in the Co-Crystal Structure of Optimized Analog Tdi-13537 Provided New Insights Into the Potency Determinants of the Sulfonamide Inhibitor Series


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 4 of Co-Crystal Structure of Optimized Analog Tdi-13537 Provided New Insights Into the Potency Determinants of the Sulfonamide Inhibitor Series within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F523

b:39.3
occ:1.00
F27 A:U4I523 0.0 39.3 1.0
C25 A:U4I523 1.4 29.6 1.0
F26 A:U4I523 2.2 39.6 1.0
C24 A:U4I523 2.4 29.5 1.0
C28 A:U4I523 2.8 25.5 1.0
O B:HOH606 3.1 42.9 1.0
CB B:GLU448 3.4 24.2 1.0
C23 A:U4I523 3.5 25.3 1.0
ND2 B:ASN382 3.5 28.6 1.0
OE2 B:GLU448 3.5 29.6 1.0
CD B:GLU448 3.5 33.6 1.0
OE1 B:GLU448 3.7 31.6 1.0
CA B:ASN382 3.9 21.9 1.0
O B:ALA381 4.0 25.7 1.0
C19 A:U4I523 4.1 27.6 1.0
CG B:GLU448 4.1 24.2 1.0
CG B:ASN382 4.1 27.7 1.0
N B:ALA383 4.1 25.2 1.0
CB B:ASN382 4.4 21.6 1.0
CZ B:PHE377 4.6 29.0 1.0
C B:ASN382 4.6 25.8 1.0
C21 A:U4I523 4.6 25.7 1.0
CA B:GLU448 4.7 22.5 1.0
C B:GLU448 4.7 25.7 1.0
O B:HOH614 4.8 33.4 1.0
C20 A:U4I523 4.9 27.5 1.0
N B:ASN382 4.9 24.9 1.0
C B:ALA381 4.9 26.1 1.0
OD1 B:ASN382 4.9 26.6 1.0
O B:THR445 4.9 22.4 1.0
CE1 B:PHE377 4.9 25.2 1.0
O B:GLU448 5.0 27.1 1.0

Reference:

M.Michino, A.Beautrait, N.A.Boyles, A.Nadupalli, A.Dementiev, S.Sun, J.Ginn, L.Baxt, R.Suto, R.Bryk, S.V.Jerome, D.J.Huggins, J.Vendome. Shape-Based Virtual Screening of A Billion-Compound Library Identifies Mycobacterial Lipoamide Dehydrogenase Inhibitors. Acs Bio Med Chem Au V. 3 507 2023.
ISSN: ESSN 2694-2437
PubMed: 38144256
DOI: 10.1021/ACSBIOMEDCHEMAU.3C00046
Page generated: Sat Aug 3 00:46:04 2024

Last articles

Mg in 4Y52
Mg in 4Y30
Mg in 4Y2V
Mg in 4Y2X
Mg in 4Y2Y
Mg in 4Y2U
Mg in 4Y2T
Mg in 4Y2Q
Mg in 4Y2R
Mg in 4Y2S
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy